FormFactor Bounces Hard, but Analysts Have Already Cut Their Cloth

FormFactor snapped back 7.4% on Friday to close at $103.90, recovering some of a bruising month that still leaves the stock down 13.6% over thirty days — and the divergence between that one-day pop and where analysts repriced targets after July earnings is the tension worth examining this week.

The options market is flashing the clearest signal of a shifting mood. Investors have rotated sharply away from downside protection: the put/call ratio has fallen to 0.82, nearly 1.4 standard deviations below its 20-day average of 1.13. Six weeks ago the PCR was at its 52-week high of 1.43, meaning the options book has essentially flipped from maximum defensiveness to something much closer to neutral-bullish. That shift has tracked the stock's partial recovery from its post-earnings lows, with call interest reasserting itself across the structure. The 52-week PCR low of 0.16 sits well below current levels, so there is room for further rotation if the recovery extends.

Short interest tells a quiet story that doesn't complicate the picture much. Bears hold 3.6% of the free float — modest for a semiconductor equipment name — and that figure has drifted down 13% over the past month. Borrowing is essentially free at around 0.42%, and availability is enormous at nearly 4,000%, meaning there are roughly 40 shares available to borrow for every one already lent out. The lending market is entirely unconstrained. This is not a stock where short positioning is exerting any meaningful pressure.

Where the story gets more textured is on the Street. Analysts were broadly constructive into the July 29 print — Citigroup, B. Riley, Craig-Hallum, and Evercore all carried bullish ratings, with targets clustered between $150 and $175. Then the earnings reaction forced a reset. TD Cowen's Krish Sankar slashed his target from $150 to $100 on July 30, keeping a Hold rating. Evercore trimmed from $155 to $150 while maintaining Outperform. The mean target now sits at roughly $138, implying about 33% upside from Friday's close — but that figure is already stale at forty days old, and at least one firm has repriced well below current levels. The bull case centres on Texas production ramp potential, gross margin expansion, and FormFactor's positioning in AI-related wafer testing. Bears point to tariff headwinds, a slowdown in margin trajectory, and revenue concentration risk. Neither side has been dominant since the print.

Institutional flows add a small wrinkle. The Vanguard Group filed a 13G/A in March disclosing a drop to zero from a prior 13.66% stake — a substantial exit. However, two separate Vanguard entities (Vanguard Capital Management and Vanguard Portfolio Management) subsequently filed new 13G positions in April totalling over 12% combined, suggesting internal restructuring rather than a strategic exit. BlackRock, the largest disclosed holder at around 12-13%, added modestly as recently as late July. EARNEST Partners trimmed its stake from 6.3% to 4.8% through August 14. No 13D activists are on the register, and the short score has nudged up only marginally to 33.8 — firmly in the lower half of the pressure spectrum. CEO Mike Slessor sold roughly $2.1 million of stock on August 14 under a pre-arranged 10b5-1 plan, which limits the signal value of those transactions considerably.

On peer context, Friday's session was broadly strong for semiconductor equipment. COHU led the group with a 10.3% single-day move, while ONTO gained 6.2% and ENTG added 6.2%. LRCX and TER each rose roughly 5%. FormFactor's 7.4% gain held its own within this cohort, though on a weekly basis NVMI and COHU have outpaced it with gains of 6.6% and 5.7% respectively, while FORM's week came in at just over 2%.

The next earnings date is October 28 — and the July print produced a 19% single-day move and a 30% five-day move, both to the upside, suggesting the stock can reprice violently on results. With the stock trading roughly 25% below the pre-earnings peak and a mean analyst target that already sits 33% above Friday's close, the setup heading into October centres on whether margin trends and AI-related probe demand can justify a renewed re-rating, or whether the post-July target cuts prove to have been the more accurate read.